Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults (Q24235890)

title

Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults (English)

0 references

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6540387&resulttype=core&format=json

14 May 2020

Dipender Gill

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6540387&resulttype=core&format=json

14 May 2020

2

Sheena Derry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6540387&resulttype=core&format=json

14 May 2020

4

R Andrew Moore

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6540387&resulttype=core&format=json

Cochrane Database of Systematic Reviews

14 May 2020

publication date

5 October 2011

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6540387&resulttype=core&format=json

14 May 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6540387&resulttype=core&format=json

14 May 2020

page(s)

CD009183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6540387&resulttype=core&format=json

Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: a prospective double-blind randomized placebo-controlled study

14 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

A phase II study to establish the efficacy and toxicity of sodium valproate in patients with cancer-related neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Sodium valproate in the management of painful neuropathy in type 2 diabetes - a randomized placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Valproic acid has no effect on pain in polyneuropathy: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

EFNS guidelines on pharmacological treatment of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Use of anticonvulsants for treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Algorithm for neuropathic pain treatment: an evidence based proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Epidemiology and treatment of neuropathic pain: the UK primary care perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Teratogenicity of antiepileptic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Meta-analysis in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Duloxetine for treating painful neuropathy or chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Anticonvulsant drugs for management of pain: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Acute pain: individual patient meta-analysis shows the impact of different ways of analysing and presenting results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Pregabalin for acute and chronic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

"Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Gabapentin for chronic neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Antidepressants for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

The epsilon theory: a novel synthesis of the underlying molecular and electrophysiological mechanisms of primary generalized epilepsy and the possible mechanism of action of valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Anticonvulsant drugs for acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Carbamazepine for acute and chronic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Lamotrigine for acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Effects of treatments for symptoms of painful diabetic neuropathy: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009183.PUB2

Oral valproic acid for epilepsy--long-term experience in therapy and side effects

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21975791

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pregabalin for acute and chronic pain in adults

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21975791

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Valproate for treatment of chronic central pain after spinal cord injury. A double-blind cross-over study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21975791

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/14651858.CD009183.PUB2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6540387&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6540387&resulttype=core&format=json

14 May 2020

1 reference